NCT04615936View on ClinicalTrials.gov

Nasal Photodisinfection COVID-19 Proof of Concept Study

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

October 13, 2020

Primary Completion Date

July 7, 2021

Study Completion Date

October 19, 2021

Conditions
COVID-19Corona Virus InfectionSARS-CoV 2
Interventions
OTHER

Methylene-Blue Photodisinfection

Participants will receive a pre-treatment nasal swab followed MB-PDF, this involves an MB nasal spray, followed by five minutes of red-light exposure into each nostril. Ten minutes after the treatment, a post treatment nasal swab will be performed.

Trial Locations (1)

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

All Listed Sponsors
lead

Sunnybrook Health Sciences Centre

OTHER

NCT04615936 - Nasal Photodisinfection COVID-19 Proof of Concept Study | Biotech Hunter | Biotech Hunter